ASU professor outlines importance of including sex chromosomes in genetic screenings


An image of several rows of blue DNA strands, with one strand glowing up, pointing to a specific gene sequence.

Genetic screening procedures identify genes that make an individual more at risk for certain diseases, improving doctors' ability to diagnose and treat their patients. A new study shows how to improve those screenings to include the sex chromosomes. Image courtesy of Cutler Integrative Medicine

|

If a doctor wants to assess a patient’s risk for getting a whole range of diseases, from cystic fibrosis to cancer, they have the incredible ability to do so by looking at the patient’s unique set of genes in a process called genetic screening.

But Melissa Wilson, an adjunct professor in the School of Life Sciences and a principal investigator with the National Institutes of Health, says that genetic screenings often overlook an important part of the human genome: the sex chromosomes.

“You can’t actually claim you’ve done genome-wide analysis if you haven’t included the X and Y,” Wilson said.

Headshot of Melissa Wilson in an outdoor setting.
Melissa Wilson

She and her colleagues recently published a study in the American Journal of Human Genetics that presented steps to better include the sex chromosomes in genetic screening, which they show can improve the accurate detection of mutations associated with diseases like Alzheimer’s, immunodeficiency and cancer.

In genetic screening, researchers use software to compare an individual’s genome to a reference genome in order to spot which of the individual’s genes are mutated. While most mutations aren’t harmful, some are associated with certain diseases.

That process of identifying harmful mutations works well for autosomes, or the non-sex chromosomes in the human body. Autosomes come in matching pairs with the same genes occurring around the same places on each chromosome, making it easy to consistently compare the autosomes to the reference genomes.

But sex chromosomes don’t always come in matching pairs. While females tend to have two X chromosomes, most males have an X and a Y chromosome that are very different from each other. There are also many other combinations, like males with XXY or females with only one X chromosome.

According to Wilson, researchers do not always take care to make sure they are using a reference genome that matches the sex chromosomes of the person they are screening. That means a researcher might compare an individual’s XX chromosomes to a reference genome with XY chromosomes (or vice versa). That can lead to classifying certain genes on the Y chromosome as having mutations when they actually do not, or missing some mutations entirely.

Wilson’s method works to both increase the number of mutations found and reduce the number of falsely identified mutations.

“We do two steps. One is making sure the reference genome is representative of the sex chromosome complement of the sample,” she said. 

That means making sure that a researcher knows the chromosome combination of their patient, and taking care to use a reference genome with chromosomes that match to be able to identify all the mutations that are present.

Though it might seem obvious what a person’s sex chromosomes are based on whether they’re male or female, Wilson insists that “you can never know what a person’s sex chromosomes are just by looking at the person — you can make an educated guess, but you really can’t know without looking at the DNA.”

Once a researcher knows they are matching up a person’s chromosomes with a reference genome to maximize the number of mutations they are finding, they can take the second step: telling the software whether there is one copy of a chromosome (making it haploid) or two copies (diploid).

In autosomes, because the genetic screening software expects there to be two chromosomes, it looks to see whether there is a mutation at the same site on each matching chromosome, or looks for two variants. Without telling the software that there is only one chromosome, the software might say there is a mutation where there actually is not. That’s how haploid calling can eliminate those false identifications.

Haploid calling is an easy step to take, Wilson said.

“Most of this software have approaches built in to call variants as haploid on chromosomes with one copy. You just have to implement that step," she explained.

“But there are major consortium efforts that never bother to take the time to implement the haploid calling or thresholds because it’s easier (not to). So we tested how big of a difference does that make, and we reduced false positives by several-fold, and increased true-positive variant detection by tens of thousands of variants.”

Wilson and her colleagues provided evidence that following the steps they lay out can greatly improve the ability to find mutations on the sex chromosomes associated with certain diseases. Now, Wilson’s job is to make sure doctors and researchers actually follow those steps:

“There’s certainly a movement to include the whole genome. But still, I sit on calls with lots of people doing really incredible work, and I still have to be the one to ask, ‘Hey, are you including the X and Y?,’ And the answer is not always yes,” she said.

“It's kind of like the autosomes take a big step forward, and the X and the Y kind of tiptoe behind. I’m just here to like, hold their hand and make sure they catch up.”

Why this research matters

Research is the invisible hand that powers America’s progress. It unlocks discoveries and creates opportunity. It develops new technologies and new ways of doing things.

Learn more about ASU discoveries that are contributing to changing the world and making America the world’s leading economic power at researchmatters.asu.edu.

More Health and medicine

 

Dr. Sarah H. Lisanby wears a navy blazer with an ASU pin on it. She is standing with her arms crossed, smiling at the camera. The background is a modern office with large windows.

ASU dean earns national recognition for work at intersection of medicine, engineering

Well before she developed brain stimulation therapies, Dr. Sarah H. Lisanby sat with patients whose conditions had no effective treatments. In high school, it was children with…

A group of people in suits turn over dirt with shovels at a groundbreaking

'At the edge of the future': ASU breaks ground for better health outcomes for Arizona

Arizona State University is taking a huge step toward addressing one of the biggest crises in the U.S. — the disparity in health care, according to ASU President Michael Crow.Crow spoke Thursday in…

Two women against an illustrated background of medical images

Putting the pieces of health care together

ASU Health has embarked on its mission to transform health care and create a new kind of health professional.ASU Health includes four academic units — two of which are new to the university ecosystem…